Remifentanil Hydrochloride
NDC 63323-723, Remifentanil Hydrochloride, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-723
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206223
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/63323-723 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REMIFENTANIL HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-723-03 | 63323072303 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-01) |
| 63323-723-06 | 63323072306 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels?ndc=63323-723
Use it
Look up 63323-723 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-723 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-723. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.